-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UxAae5THux+KW8LF5abzhU2vxamMcvlDkJ3SZnGZmLEYGV1vEOF1gJfiGUKu9KO5 W8TNG/6w6nFPzos7sitKaw== 0001193805-07-002147.txt : 20070817 0001193805-07-002147.hdr.sgml : 20070817 20070817172330 ACCESSION NUMBER: 0001193805-07-002147 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070806 FILED AS OF DATE: 20070817 DATE AS OF CHANGE: 20070817 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHCARE ACQUISITION CORP CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2116 FINANCIAL CENTER STREET 2: 666 WALNUT STREET CITY: DES MOINES STATE: IA ZIP: 50309 BUSINESS PHONE: 515-244-5746 MAIL ADDRESS: STREET 1: 2116 FINANCIAL CENTER STREET 2: 666 WALNUT STREET CITY: DES MOINES STATE: IA ZIP: 50309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RICHMAN ERIC I CENTRAL INDEX KEY: 0001313876 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 071065973 BUSINESS ADDRESS: BUSINESS PHONE: 212-682-3096 MAIL ADDRESS: STREET 1: LEV PHARMACEUTICALS INC STREET 2: 122 EAST 42ND STREET STE 206 CITY: NEW YORK STATE: NY ZIP: 10022 3 1 e602486_ex.xml FORM 3 X0202 3 2007-08-06 0 0001326190 HEALTHCARE ACQUISITION CORP PIP 0001313876 RICHMAN ERIC I C/O PHARMATHENE, INC. ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 0 1 0 0 Sr. VP, Business Development Stock Option (right to buy) 3.28 2004-11-15 2013-11-15 Common Stock 21535 D Stock Option (right to buy) 4.22 2005-01-18 2015-01-18 Common Stock 10195 D Stock Option (right to buy) 4.22 2006-01-01 2016-01-01 Common Stock 3001 D Stock Option (right to buy) 4.22 2007-01-04 2017-01-04 Common Stock 2034 D 8% Convertible Notes 10.00 2007-08-03 2009-08-03 Common Stock 820 D 25% of the shares shall vest each year commencing on the first anniversary after the option grant date of November 15, 2003. Received in exchange for existing stock options in the Target. Pursuant to the Agreement and Plan of Merger, dated as of January 19, 2007, among the Issuer, PAI Acquisition Corp., a Delaware Corporation and a direct wholly-owned subsidiary of the Issuer ("Merger Sub"), and PharmAthene, Inc., a privately held Delaware corporation ("Target"), whereby Merger Sub merged with and into Target as a result of which Target became a wholly-owned subsidiary of the Issuer (the "Merger"). 25% of the shares shall vest immediately on the option grant dates of January 18, 2005 and January 1, 2006, respectively. Beginning on the first day of the second month following the option grant dates, the shares vest monthly in 1/36th increments over the next 36 months. The option vests as of the first day of each month in 1/36th increments over the 36 months immediately following the option grant date of January 4, 2007. Received in the Merger in exchange for existing convertible notes of the target in the principal amount of $8,200 (plus accrued interest). /s/ Eric Richman 2007-08-17 -----END PRIVACY-ENHANCED MESSAGE-----